Metabolic-oncological MR imaging of diffuse low-grade glioma: A dynamic approach

Abstract

Today, magnetic resonance imaging is the gold standard of brain tumor imaging, but remains widely used only under its conventional aspect. Recent advances on MRI sequences development and use provided a new conceptual approach of diagnosis and follow-up of WHO II glioma based on multiparametrical and dynamic study of their metabolism allowed by spectroscopy (even multinuclear) and perfusion-weighted imaging, namely, oncological biometabolic imaging. We discuss in this chapter the different aspects and methodological issues and address some practical consequences on MRI clinical practice.